opioids
New York (AFP) - Publicis Health will pay $350 million to settle charges from US states that its "predatory and deceptive marketing strategies" worsened the opioid epidemic, New York's top prosecutor said Thursday. Publicis Health, part of the French advertising giant Publicis, worked with Purdue Pharma between 2010 and 2019 on marketing material to promote OxyContin and other drugs, New York Attorney General Letitia James said in a press release. She said the agreement was the first with an advertising agency for its role in the opioid epidemic. "For a decade, Publicis helped opioid manufac...
AFP
Washington (AFP) - The US drug regulator announced Wednesday that Narcan, the treatment which reverses overdoses, can be distributed without prescription, a move that comes as the country battles an acute opioid addiction crisis. The Federal Drug Administration (FDA) said that four milligram nasal spray doses of naloxone hydrochloride, the generic name for Narcan, can be sold over the counter almost anywhere, from pharmacies to supermarkets to gas stations. The FDA said they moved to address to mounting toll from opioid use, especially the synthetic and relatively easily made fentanyl, which h...
AFP
Washington (AFP) - When a person suffers an opioid overdose, their respiration is "slowed to the point that you're not breathing," social worker Johnny Bailey explains, speaking to a rapt audience at a nonprofit office in Washington earlier this month. Bailey is training attendees in the use of Narcan, a drug that reverses overdoses caused by opioids such as fentanyl, a narcotic 50 times more powerful than heroin. Narcan will "bring someone back from basically the dead," the 47-year-old recovered drug addict said at the offices of HIPS, an organization that provides "harm reduction" services t...
AFP
New York (AFP) - US pharmacy chains CVS Health and Walgreens said Wednesday they had reached preliminary agreements to together pay more than $10 billion to resolve opioid claims from US states, cities and tribes. The opioid crisis, which has caused more than 500,000 deaths over 20 years in the United States, has triggered a flurry of lawsuits against drugmakers, distributors and pharmacies from victims as well as cities, counties and states. The pharmacies' agreements in principal are for much bigger sums than previously agreed by pharmacy chains, putting that sector in the same ballpark as d...
AFP
Washington (AFP) - Israeli generic drug maker Teva has reached an agreement in principle to pay $4.25 billion over 13 years to settle a series of court cases over its role in the US opioid epidemic. If the deal is finalized, Teva would become the latest major company to reach a settlement over the crisis which caused hundreds of thousands of deaths and ravaged communities across the country. Teva reached the potential agreement on the terms of a "nationwide opioids settlement" with a working group of state attorneys general and lawyers for Native American tribes and other plaintiffs, the compa...
AFP
New York (AFP) - Survivors of opioid abuse and relatives of victims delivered emotional and stinging rebukes on Thursday to members of the Sackler family, owners of Purdue Pharma, accused of fueling the US addiction crisis. As part of Purdue Pharma's bankruptcy settlement, members of the Sackler family were compelled to listen at an extraordinary court hearing to the stories of opioid victims and their relatives. "We buried Matthew and Kyle because of your family's vicious acts of disregard for human life," Liz Fitzgerald said of the deaths of two of her sons. "Two boys are gone because of you...
AFP
Washington (AFP) - The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the US opioid crisis to settle an avalanche of litigation, according to a report filed Friday by a federal mediator. The Sackler family's new offer would raise by at least a billion dollars a $4.5 billion bankruptcy settlement thrown out by a US judge in December over language that would have shielded the family from further lawsuits involving the highly addictive prescription painkiller. Under the new proposal, the Sacklers "would be paying, in total, not less than $5.5 billi...
AFP
New York (AFP) - A US judge on Thursday struck down the Purdue Pharma bankruptcy plan because it provided some immunity for the owners of the company in exchange for a $4.5 billion payout to victims of the opioid crisis. In her decision, seen by AFP, Judge Colleen McMahon said the federal judge who approved the pharmaceutical company's bankruptcy plan in September did not have authority to prevent future lawsuits against members of the Sackler family, except in cases of intentional misconduct. Forty-three US states had approved the plan but the Justice Department and a handful of other states ...
AFP
New York (AFP) - New York's Metropolitan Museum of Art said Thursday it was stripping the Sackler name from several exhibition wings, amid ongoing controversy over the billionaire family's alleged role in fueling the opioid crisis. The Sackler name will be removed from seven exhibitions, among them the wing housing the Temple of Dendur, the Met said in a joint statement with the family. The Sacklers -- long a major benefactor of museums and prestigious universities -- owned pharmaceutical giant Purdue Pharma, and are accused of profiting off the sale of the opioid OxyContin that is blamed for ...
AFP
Washington (AFP) - The US Justice Department has challenged a plan that would dissolve Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the country's opioid crisis, while shielding its founders from lawsuits. The government wants the settlement, which was approved this month by a federal judge, to be put on hold while prosecutors challenge it in a federal appeals court. Under the deal, the Sackler families that founded and profited from the company would have to pay $4.5 billion, but they could not be taken to court again over the drug. In a court filing released Wed...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら